Gene expression profiling for individualized breast cancer chemotherapy: success or not?

被引：8

作者：

Ioannidis, John P. A. ^{[1
]}

机构：

[1] Univ Ioannina, Dept Hyg & Epidemiol, Sch Med, GR-45110 Ioannina, Greece

[2] Tufts Univ, Sch Med, Boston, MA 02111 USA

来源：

NATURE CLINICAL PRACTICE ONCOLOGY | 2006年 / 3卷 / 10期

关键词：

adjuvant chemotherapy; breast cancer; estrogen receptor; node-negative; recurrence;

D O I：

10.1038/ncponc0631

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：538 / 539

页数：2

共 4 条

[1] Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer [J].

Ein-Dor, L ;

Zuk, O ;

Domany, E .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (15) :5923-5928

[2] Microarrays and molecular research: noise discovery? [J].

Ioannidis, JPA .

LANCET, 2005, 365 (9458) :454-455

[3] Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment [J].

Ntzani, EE ;

Ioannidis, JPA .

LANCET, 2003, 362 (9394) :1439-1444

[4] A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer [J].

Paik, S ;

Shak, S ;

Tang, G ;

Kim, C ;

Baker, J ;

Cronin, M ;

Baehner, FL ;

Walker, MG ;

Watson, D ;

Park, T ;

Hiller, W ;

Fisher, ER ;

Wickerham, DL ;

Bryant, J ;

Wolmark, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2817-2826

← 1 →